Why the study?
Does Cardiac Resynchronization Therapy improve QRS duration, NYHA functional status, and SRV function in adult patients with a failing systemic right ventricle?
Does Cardiac Resynchronization Therapy improve QRS duration, NYHA functional status, and SRV function in adult patients with a failing systemic right ventricle?
In adult patients with a failing systemic right ventricle and pacing-induced dyssynchrony, CRT may improve QRS duration and functional status, though these benefits may not extend to those receiving de novo CRT.
Answers are grounded in this paper and cite their sources.
May support CRT upgrade in paced failing SRV; leaves open de novo efficacy and needs randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kharbanda et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: